Glaxosmithkline (GSK) and Roche, the two original drugmaker of Swine flu drug said they have no immediate plans to launch their drugs in the Indian retail Market as their priority is to supply to governments globally. This leaves five Indian generic companies Cipla, Ranbaxy, Hetero Natco and Stride Arcolab to compete in the retail Market.
Related Pages :
